Clover Biopharmaceuticals Ltd.'s total assets for Q2 2024 were ¥1.80B, a decrease of -14.47% from the previous quarter. HK:2197 total liabilities were ¥2.63B for the fiscal quarter, a -7.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.